Equities Analysts Set Expectations for CMPX Q2 Earnings
Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) – Equities researchers at HC Wainwright decreased their Q2 2025 earnings per share estimates for shares of Compass Therapeutics in a research note issued to investors on Thursday, May 8th. HC Wainwright analyst J. Pantginis now expects that the company will post earnings of ($0.13) per share for […]
